CLDN18 and atherosclerosis: Considering that atherosclerosis is a chronic inflammatory disease, it is conceivable that such a pathological process may promote the induction of CLDN18 in endothelial cells, thereby not only altering endothelial barrier properties but also influencing the transcriptional programs of circulating PBMCs [31,32].